Svensson M - Search Results

1

Plasma levels of marine n-3 fatty acids and cardiovascular risk markers in renal transplant recipients.

Eide IA, Dahle DO, Svensson M, Hartmann A, Åsberg A, Bjerve KS, Christensen JH, Schmidt EB, Lauritsen ME, Lund K, Jenssen T. Eide IA, et al. Among authors: svensson m. Eur J Clin Nutr. 2016 Jul;70(7):824-30. doi: 10.1038/ejcn.2016.14. Epub 2016 Mar 2. Eur J Clin Nutr. 2016. PMID: 26931669

2

The effect of n-3 fatty acids on plasma lipids and lipoproteins and blood pressure in patients with CRF.

Svensson M, Christensen JH, Sølling J, Schmidt EB. Svensson M, et al. Am J Kidney Dis. 2004 Jul;44(1):77-83. doi: 10.1053/j.ajkd.2004.03.024. Am J Kidney Dis. 2004. PMID: 15211441 Clinical Trial.

3

The effect of n-3 fatty acids on heart rate variability in patients treated with chronic hemodialysis.

Svensson M, Schmidt EB, Jørgensen KA, Christensen JH. Svensson M, et al. J Ren Nutr. 2007 Jul;17(4):243-9. doi: 10.1053/j.jrn.2007.02.004. J Ren Nutr. 2007. PMID: 17586422 Clinical Trial.

4

N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial.

Svensson M, Schmidt EB, Jørgensen KA, Christensen JH; OPACH Study Group. Svensson M, et al. Clin J Am Soc Nephrol. 2006 Jul;1(4):780-6. doi: 10.2215/CJN.00630206. Epub 2006 Jun 14. Clin J Am Soc Nephrol. 2006. PMID: 17699287 Clinical Trial.

5

The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.

Svensson M, Schmidt EB, Jørgensen KA, Christensen JH. Svensson M, et al. Nephrol Dial Transplant. 2008 Sep;23(9):2918-24. doi: 10.1093/ndt/gfn180. Epub 2008 Apr 24. Nephrol Dial Transplant. 2008. PMID: 18436564 Clinical Trial.

6

NT-pro-BNP is an independent predictor of mortality in patients with end-stage renal disease.

Svensson M, Gorst-Rasmussen A, Schmidt EB, Jorgensen KA, Christensen JH. Svensson M, et al. Clin Nephrol. 2009 Apr;71(4):380-6. doi: 10.5414/cnp71380. Clin Nephrol. 2009. PMID: 19356370

7

N-3 fatty acids and cardiac autonomic function in humans.

Christensen JH, Svensson M, Strandhave C, Madsen T, Schmidt EB. Christensen JH, et al. Among authors: svensson m. Cell Mol Biol (Noisy-le-grand). 2010 Feb 25;56(1):131-9. Cell Mol Biol (Noisy-le-grand). 2010. PMID: 20196976

8

The effect of n-3 fatty acids on levels of methylarginines in patients with end-stage renal disease.

Svensson M, Frøbert O, Schmidt EB, Jørgensen KA, Simonsen U, Christensen JH. Svensson M, et al. J Nephrol. 2010 Jul-Aug;23(4):459-64. J Nephrol. 2010. PMID: 20349405 Clinical Trial.

9

Marine n-3 polyunsaturated fatty acids in patients with end-stage renal failure and in subjects without kidney disease: a comparative study.

Madsen T, Christensen JH, Svensson M, Witt PM, Toft E, Schmidt EB. Madsen T, et al. Among authors: svensson m. J Ren Nutr. 2011 Mar;21(2):169-75. doi: 10.1053/j.jrn.2010.06.020. Epub 2010 Sep 15. J Ren Nutr. 2011. PMID: 20833075

10

The content of docosahexaenoic acid in serum phospholipid is inversely correlated with plasma homocysteine levels in patients with end-stage renal disease.

Rasmussen LE, Svensson M, Jørgensen KA, Schmidt EB, Christensen JH. Rasmussen LE, et al. Among authors: svensson m. Nutr Res. 2010 Aug;30(8):535-40. doi: 10.1016/j.nutres.2010.07.004. Nutr Res. 2010. PMID: 20851307 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,151 results

Search Page

Filters